Compare LMAT & NMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LMAT | NMM |
|---|---|---|
| Founded | 1983 | 2007 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2006 | 2007 |
| Metric | LMAT | NMM |
|---|---|---|
| Price | $112.64 | $70.56 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $105.80 | N/A |
| AVG Volume (30 Days) | ★ 202.3K | 160.3K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.89% | 0.34% |
| EPS Growth | ★ 30.57 | N/A |
| EPS | ★ 2.52 | N/A |
| Revenue | ★ $249,602,000.00 | N/A |
| Revenue This Year | $14.21 | $5.57 |
| Revenue Next Year | $8.88 | $3.66 |
| P/E Ratio | $44.76 | ★ $7.24 |
| Revenue Growth | ★ 13.53 | N/A |
| 52 Week Low | $78.01 | $31.13 |
| 52 Week High | $115.33 | $74.21 |
| Indicator | LMAT | NMM |
|---|---|---|
| Relative Strength Index (RSI) | 64.22 | 57.58 |
| Support Level | $81.60 | $49.57 |
| Resistance Level | $113.40 | $74.21 |
| Average True Range (ATR) | 3.48 | 2.69 |
| MACD | -0.28 | 0.44 |
| Stochastic Oscillator | 90.48 | 75.58 |
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
Navios Maritime Partners LP is an international owner and operator of dry cargo and tanker vessels. Its vessels are generally chartered-out under short-term, medium-term and long-term time charters with an average remaining charter duration of approximately 2.1 years to a group of counterparties. Its fleet consisted of dry bulk vessels, containerships and tanker vessels, including two newbuilding capesize vessels, newbuilding containerships and newbuilding tankers. It operates in single segment.